EBITDA (Quarterly)

EBITDA: Income before interest, taxes, depreciation and amortization.

Jaguar Animal Health, Inc. (JAGX) had EBITDA of $-6.62M for the most recently reported fiscal quarter, ending 2026-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$1.23M
Net Income	$-12.70M
Cost of Goods Sold	$1.03M
Gross Profit	$0.19M
Operating Expenses	$8.82M
Operating Income	$-7.60M
Non-Operating Income/Expense	$-5.21M
Pre-Tax Income	$-12.80M
Normalized Pre-Tax Income	$-12.80M
Income after Taxes	$-12.80M
Income from Continuous Operations	$-12.80M
Consolidated Net Income/Loss	$-12.80M
Normalized Income after Taxes	$-12.80M
EBIT	$-7.60M
EBITDA	$-6.62M
Weighted-Average Shares Outstanding (Basic)	0.81M
Weighted-Average Shares Outstanding (Diluted)	0.81M
Earnings per Share (EPS) (Basic)	$-15.70
Earnings per Share (EPS) (Diluted)	$-15.70
Balance Sheet Financials
Current Assets	$17.53M
Property, Plant, and Equipment	$0.42M
Long-Term Assets	$16.66M
Total Assets	$34.19M
Current Liabilities	$25.38M
Long-Term Debt	$1.73M
Long-Term Liabilities	$3.89M
Total Liabilities	$29.27M
Common Equity	$4.92M
Tangible Shareholders Equity	$-10.16M
Shareholders Equity	$4.92M
Common Shares Outstanding	4.86M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$3.49M
Cash Flow from Investing Activities	--
Cash Flow from Financial Activities	$-4.75M
Beginning Cash	$7.83M
End Cash	$6.59M
Increase/Decrease in Cash	$-1.24M
Stock-Based Compensation	$0.33M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.69
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.26
Debt to Equity Ratio	3.16
Gross Margin	15.84%
Operating Margin	-620.16%
EBIT Margin	-620.16%
EBITDA Margin	--
Pre-Tax Profit Margin	-1045.06%
Profit Margin	-1036.82%
Free Cash Flow	$3.49M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.04
Inventory Turnover	0.14
Receiveable Turnover	6.19
Days Sales in Receivables	14.55
Return on Equity	-260.15%
Return on Tangible Equity	125.94%
Return on Assets	-37.44%
Return on Investments	-192.60%
Book Value Per Share	$1.01
Free Cash Flow per Share	$4.32
Operating Cash Flow per Share	$4.32

Data from Zacks Investment Research, Inc.